SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-17-004263
Filing Date
2017-04-21
Accepted
2017-04-21 06:15:45
Documents
8
Period of Report
2017-04-21
Effectiveness Date
2017-04-21

Document Format Files

Seq Description Document Type Size
1 def14a.htm DEF 14A 680626
2 image_003.jpg GRAPHIC 16639
3 image_004.jpg GRAPHIC 8844
4 image_005.jpg GRAPHIC 12169
5 image_006.jpg GRAPHIC 9069
6 image_002.jpg GRAPHIC 7227
7 image_007.jpg GRAPHIC 145435
8 image_008.jpg GRAPHIC 84812
  Complete submission text file 0001493152-17-004263.txt   1073802
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37428 | Film No.: 17774161
SIC: 2834 Pharmaceutical Preparations